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Age-related hearing loss is a multi-factorial process involving genetic and environmental factors,
including exposure to noise and ototoxic agents, as well as pathological processes. Among these is the
accumulation of mitochondrial DNA mutations and deletions. The creation of a transgenic mouse with
a loss-of-function deletion of the nuclear gene that encodes the polymerase required to repair damaged
mitochondrial DNA (PolgA) enabled evaluation of age-related cochlear pathology associated with random
mitochondrial DNA deletions that accrue over the lifespan of the mouse.
In comparison with their wild-type or heterozygous counterparts, animals with mutated DNA poly-
merase gamma developed hearing loss most rapidly. Any loss of mitochondrial DNA polymerase function
however, resulted in detrimental effects, as evidenced by hearing tests and histological investigation of
transgenic heterozygotes. Cochlear pathology in transgenic animals at 10 months of age included loss of
neurons and clumping of surviving neurons in the apical turn of the spiral ganglion. Mitochondrial
mutations in young animals, on the other hand, were protective against the development of temporary
threshold shift in response to relatively low level noise exposure. This supports the idea that temporary
threshold shifts are the result of an active process involving mitochondria and respiratory chain activity.
Our results indicate that mitochondrial mutation and deletion can certainly contribute to the develop-
ment of an aging phenotype, speciﬁcally age-related hearing loss.
 2011 Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction neural cells as well as the stria vascularis (Schuknecht and Gacek,Presbycusis, or age-related hearing loss, affects an estimated
40% of individuals over the age of 65 years. It is a multi-factorial
process involving genetic factors, environmental factors, such as
exposure to noise and ototoxic agents, as well as pathological
processes. It is experienced as an elevation in hearing thresholds
occurring over time (Gates and Mills, 2005) and is accompanied by
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-NC-ND license.1993). The morbidity of this disease is largely due to impairment
in speech recognition and discrimination, especially in noisy
environments, resulting in social isolation and an inability to
compensate for other age-related disabilities.
One of the many hypothetical contributors to systemic and
cochlear aging is the accumulation of mitochondrial DNA (mtDNA)
damage, both mutations and deletions that lead to mitochondrial
inefﬁciency (Ames, 2004; Fischel-Ghodsian et al., 1997; Seidman
et al., 2004; Yamasoba et al., 2007). As mitochondria are respon-
sible for the energy production and therefore survival of each cell,
when mtDNA mutations reach a threshold level that renders
enough organelles bioenergetically inefﬁcient, the cell dies.
In order to investigate this phenomenon and its role in aging,
transgenic mice (D257A) were generated with two altered residues
in the nuclear DNA domain of the polymerase gamma gene (POLG)
locus, impairing its proofreading ability (Trifunovic et al., 2004;
Kujoth et al., 2005). This nuclear-encoded gene produces the cata-
lytic subunit of the mtDNA polymerase, the only polymerase with
conﬁrmed activity within the mitochondrial genome (Hübscher
et al., 1979). As a consequence of this mutation, mtDNA of trans-
genic animals accumulates unrepaired damage at a higher rate than
in normal mice (Trifunovic et al., 2004; Kujoth et al., 2005; Kujoth
and Prolla, 2008). These PolgA mice do not produce a measurable
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but they do display progressive respiratory chain dysfunction
(Edgar et al., 2009). By 7e9 months of age transgenic mice
demonstrate some of the stigmata of aging: kyphosis, alopecia,
weight loss, decreased bone mineral density and content, anemia,
and reduction in fertility. They also develop premature presbycusis
with elevated auditory brainstem response (ABR) thresholds and
a loss of auditory ganglion cells by the age of 9months (Kujoth et al.,
2005; Someya et al., 2008; Niu et al., 2007). Presbycusis in these
subjects has been associatedwithmtDNA transcriptional changes in
cochlear tissues correlating with a decline in energy metabolism,
cytoskeletal dysfunction, hearing loss and induction of apoptosis
(Someya et al., 2008).
The present work supports the proposal that random mtDNA
mutations and deletions can lead to hearing loss and cochlear
pathology similar to that seen in age-related hearing loss. A cohort of
subjects was selected for examination at regular intervals over the
course of a year. Animalswith doublemutations at the nuclear POLG
locus and their original background,wild-typeB6 animals have been
studied (Kujoth et al., 2005; Someya et al., 2008; Niu et al., 2007)
with acknowledgement that the background strain carries the ahl
allele of the Cdh23 gene responsible for early onset hearing loss
(Noben-Trauth et al., 2003; Mikaelian et al., 1974). We additionally
included genotypic nuclear wild-type animals from our colony that
were exposed at conception to the mitochondrial pools of their
heterozygotic mothers, as well as nuclear heterozygotes for the
PolgA gene. Observing representatives of all these genotypic variants
allowed for a comparison of the effects of variable amounts of
mtDNA damage: damage present in the embryo at conception and
damage thatwould accumulate throughout development and aging.
We hypothesized that widespread, random mtDNA mutation
would affect all cell types within the inner ear according to their
energy requirements and the random pattern of mutation. We also
expected that resultant dysfunction would produce measurable
disparities in ABR and distortion product otoacoustic emission
(DPOAE) thresholds. We anticipated that the greatest cochlear
pathology would occur in cell types with the greatest requirement
for metabolic energy such as the hair cells, cells of the stria vas-
cularis, spiral ligament, and auditory neurons. We also examined
the activity of one protein encoded in mtDNA, cytochrome oxidase
(COX), in cochleas of advancing age. Because we predicted that
right and left ears would be affected independently, we measured
and compared the two ears in individual animals. In order to test
the ability of transgenic mice to respond to and recover from
acoustic trauma, we selected a separate group of young animals and
exposed them to loud noise, while following their acute and
subacute responses as measured by ABR.
2. Materials and methods
2.1. Animals
The experimental cohort utilized for this project was developed
from 3 females and 1 male heterozygous D257A mice, PolgA mice
generously given to us by Drs. Tomas Prolla and Greg Kujoth
(University of Wisconsin, Madison, WI, USA). In our animal facility,
the mice were bred to establish a colony of homozygous (D257A),
heterozygous (D257A/þ) and chromosomal wild-type (WT) mice.
B6 (C57BL/6) mice were purchased from the Jackson Laboratory
(Bar Harbor, ME, USA) for use as wild-type controls.
All animals were housed in standard polyurethane cages with
free access to food and water in a temperature and light-regulated
room. The use of these animals was performed in accordance with
regulations and training established by the Veterinary Medical Unit
of the Veterans Affairs San Diego Healthcare System.2.2. Physiologic assessment of hearing
Bilateral hearing tests were performed in 8 mice from each
genotype every month from 2 to 10 months of age. The test con-
sisted of ABRs and DPOAEs collected with SigGen and BioSig
computer software and System 3 hardware (Tucker-Davis Tech-
nologies, Alachua, FL, USA). Prior to testing, anesthesia was ach-
ieved with an initial dose of ketamine hydrochloride (50 mg/kg),
xylazine hydrochloride (5 mg/kg) and acepromazine maleate
(1 mg/kg). If additional doses were required to maintain anesthesia
during testing, they were administered at 30e40% of the initial
dose. Anesthetized mice were positioned on a heating pad main-
tained at 37 C in a single-walled acoustic booth (Industrial
Acoustics Co., Bronx, NY USA). A speculumwith 2 EC1 speakers and
an ER10Bþ microphone probe (Etymotic Research, Elk Grove
Village, IL, USA) was placed tightly into the external auditory canal.
For the ABR recordings, electrodes (Astro-Med, Inc., Grass Instru-
ment Division, West Warwick, RI, USA) were inserted subdermally
at the vertex, mastoid and distal paraspinal regions.
ABRs were elicited with click stimuli (0.1 ms; 10/s, alternating
polarity) delivered to the subject via one of the speakers inserted
into its ear. Pure-tone stimuli (tone pips at 8, 16 and 32 kHz) were
also employed in ABR testing for all subjects during the testing
session at the 9th-month of age. The stimulus-locked ABR was
ampliﬁed and ﬁltered, using a battery-operated ampliﬁer with the
output connected to the computer. The click stimuli were presented
with progressive attenuation from 90 dB to 0 dB in 5 dB increments,
and the recorded stimulus-locked activity was averaged (n ¼ 512).
Threshold was deﬁned as the stimulus intensity level between the
level that induced a clearly visualized brainstem potential and one
that did not. If the threshold exceeded 90 dB, 95 dB was assigned as
the value of threshold.
Cubic DPOAE were measured at 6, 8, 16, 20, and 28 kHz using
equal intensity primary tones with ratios of 0.894 and 1.118 of the
center frequencies. The stimulus intensity was increased in 5 dB
increments from 0 to 70 dB to establish the 2f1-f2 thresholds. Mean
DPOAE thresholds for each frequency were deﬁned as the lowest
intensity at which the distortion product was 2e3 dB above the
noise ﬂoor. If a response was not detected at a measureable
intensity, a level of 75 dB was assigned as the threshold.
2.3. COX activity assay
To histologically assess mitochondrial function, we adapted
a histochemical assay that demonstrates the relative activity of the
mitochondrial enzyme, COX (Wong-Riley, 1979). This enzyme is
coded by the mtDNA and is a component of the respiratory chain
acting within the mitochondria. Its activity was assessed by incu-
bating tissues with the substrate, cytochrome c and the chromagen,
diaminobenzidine (DAB) for visualization in histological sections.
Mice of all genotypes that had previously undergone hearing
assessment were sacriﬁced and their cochleas were quickly
removed by microdissection. The cochlea with the worst hearing at
10 months of age was selected for the COX assay. In order to ensure
that our incubation solution rapidly reached cochlear tissues, the
stapes was removed, the oval window punctured and a small
section of bone from the apical-lateral aspect of the cochlear
capsule was removed. The cochlea was then placed in PBS until
each cochlea from a group of 3e4 mice had been harvested. They
were subsequently immersed in a solution containing 3,30-DAB,
cytochrome c and catalase (Sigma). Cochleas were incubated for 4 h
at 37 C with continuous gentle agitation. Cochleas were then
removed from the DAB solution and ﬁxed by immersion in 1.5%
paraformaldehyde/2.5% glutaraldehyde, phosphate buffered ﬁxa-
tive for at least 12 h at room temperature. To provide a negative
Fig. 1. Transgenic mice with variable amounts of mutated mtDNA polymerase (PolgA)
do not gain weight after 3 months of age. Transgenic homozygous (D257A), hetero-
zygous (D257A/þ) and mice derived from heterozygous mothers (WT) are all affected.
The background strain, B6, gains about 8 g after 3 months of age. Stars represent
statistically signiﬁcant difference between D257A and B6 (ANOVA, p < 0.001, Fisher’s
Least Signiﬁcant Difference post-hoc test).
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potassium cyanide to the solution of the control cochlea run with
each assay. Following ﬁxation, the cochleas were decalciﬁed in 10%
EDTA for 5e7 days, cryosectioned (9 mm) and mounted on super-
frost plus (Fisher Scientiﬁc) slides. Half of all sections were subse-
quently counterstained with cresyl violet in order to clearly
delineate relevant structures. Three sections from each enzymati-
cally reacted cochlea (B6 n ¼ 5, D257A n ¼ 6, D257A/þ n ¼ 5, WT
n ¼ 7 cochleas) were analyzed by one of the authors who did not
knowwhich sections were fromwhich genotype. An Olympus light
microscope was used to assess the relative density of the DAB
staining in the stria vascularis, spiral ligament, Reissner’s
membrane, hair cells, auditory neurons and limbus. A value of 0e5
(very dark staining) was given to each of these structures in each
section. A mean score was calculated for each structure within each
genotype. An ANOVA statistical test with a Fisher’s Least Signiﬁcant
Difference post-hoc test was used to determine if there was
a difference among the genotypes for each labeled structure.
2.4. Tissue preparation for histology
A total of 48 mice (n ¼ 18 D257A, n ¼ 14 D257A/þ, n ¼ 12 WT,
n ¼ 4 B6) including those that were processed for the COX assay,
were evaluated for cochlear pathology. Thesemice ranged from 3 to
16 months of age. All mice were born and raised in our colony. The
oldest mice had not been used for prior experimentation. These
mice were anesthetized as described above and intracardially
perfused with 2% paraformaldehyde and 1% glutaraldehyde in
phosphate buffer and kept at 4 C for 12 h. Cochleas were then
dissected from the skull and prepared for frozen or parafﬁn
sectioning (10 mm). Sections were stained with cresyl violet or
hematoxylin and eosin and evaluated using an Olympus light
microscope.
2.5. Acoustic trauma
In order to evaluate the effect of mtDNA mutations on the
cochlear response to loud noise, a separate cohort of 2-month-old
mice composed of individuals from each genotypic group (B6, WT,
D257A/þ, D257A) was selected and exposed to an octave-band
noise (8e16 kHz) at an intensity of either 95 dB or 105 dB for
140 min. Bilateral ABRs were measured just prior to the noise
exposure, immediately following the exposure and again one
month later. Noise exposure was performed by placing subjects in
a cagewithin a custommade Plexiglas sound chamber (Wang et al.,
2002). White noise was generated by a Grason & Stadler model
1208 noise generator, ﬁltered through a Krohn-Hite model 3750
ﬁlter and ampliﬁed with a Crown ampliﬁer. A model 2446H JBL
speaker positioned on the top of the sound chamber was used to
deliver the sound to 4 mice simultaneously. The sound level at the
animals’ head was measured using a hand-held Brüel and Kjaer
model 2209 sound level meter.
3. Results
3.1. Animals
All subjects were weighed prior to each hearing test session and
weights were recorded each month (Fig. 1). Though all mice gained
weight through their third month of age, regardless of genotype,
only unrelated B6 mice continued to gain weight steadily
throughout the 10-month observation period. Homozygous mice
(D257A) did not gainweight after their thirdmonth. By 7months of
age the D257Amice were signiﬁcantly lighter than the B6 mice and
this difference increased over the next 4 months (ANOVA,p < 0.001, Fisher’s Least Signiﬁcant Difference post-hoc test).
Although the mean weight of the D257A mice was lower than that
of the heterozygotes (D257A/þ) and nuclear wild-type transgenic
mice (WT) this difference was not statistically different.
3.2. Physiologic assessment of hearing
The DPOAE thresholds were measured bilaterally for each
subject from the ages of 2e10 months on a monthly basis. At 2
months, the mice were maximally sensitive at 16 kHz with an
average threshold of 12 dB. At 28 kHz, mean threshold for all
genotypes was 54 dB. There was no difference among genotypes.
ABR thresholds persistently increased, especially at high frequen-
cies, with each subsequent monthly testing in all genotypes (Fig. 2).
Many of the animals had reached maximum measurable threshold
for 20 and 28 kHz by the age of 6months. By 10months of age, none
of the animals had measureable thresholds at 20 and 28 kHz. The
only frequencies that yielded differences among genotypic groups
were the relatively low frequencies, 6 and 8 kHz. Though all
subjects beganwith low-frequency thresholds of 20 dB or less, by 7
and at 8 and 9 months D257A mice demonstrated thresholds that
were greater than the B6 mice (ANOVA, p < 0.05, Fisher’s Least
Signiﬁcant Difference post-hoc test). By 10 months however, there
was no signiﬁcant difference among the groups at any frequency.
Bilateral ABR testing performed concurrently with DPOAE tests
showed that all 4 genotypes elevations in mean ABR thresholds as
they aged (Fig. 3). By 7 months of age, all transgenic genotypes
demonstrated some level of hearing loss greater than the B6,
control group. The mean threshold of the D257A mice was signif-
icantly worse than that of the B6 cohort (p < 0.05, ANOVA, Fisher’s
Least Signiﬁcant Difference post-hoc test). This pattern was main-
tained as each group’s hearing continued to deteriorate over the
subsequent 3-month testing period. At the ages of 8 and 9 months,
both D257A/þ and D257A mice had signiﬁcantly higher thresholds
than the corresponding mean B6 threshold (p < 0.04, ANOVA,
Fisher’s Least Signiﬁcant Difference post-hoc test). At 10 months
however, only the D257A/þ group maintained its signiﬁcant
difference (p < 0.05) from the B6 group. Overall, B6 subjects
experienced an elevation of 15 dB in mean ABR thresholds while
mean threshold elevations of 30 and 27 dB were seen in D257A and
D257A/þmice groups, respectively. Transgenic wild-type mice also
demonstrated increased thresholds, culminating in a ﬁnal average
elevation of 22 dB.
Fig. 2. Mean DPOAE threshold for each genotypic group at 4, 6, 8 and 10 months of age. All groups experienced high frequency DPOAE losses beginning at 6 months of age. Mean
DPOAE thresholds at 8 months depict low frequency increases in transgenic animals compared with the background strain, B6 mice (ANOVA p < 0.05, Fisher’s Least Signiﬁcant
Difference post-hoc test). At 10 months however, these small increases did not reach statistical signiﬁcance. B6, solid diamonds; WT, solid squares; D257/þ, solid triangles; D257A,
open circles.
B.K. Crawley, E.M. Keithley / Hearing Research 280 (2011) 201e208204To determine whether the auditory nerve thresholds measured
by ABR were greater than the hair cell thresholds from DPOAE
measurements, 8 kHz tone-pips were used to test ABR thresholds at
9 months of age. These results are plotted against the mean DPOAE
threshold at 8 kHz for each genotypic group (Fig. 4). The results
suggest that the loss of neural activity at 8 kHz does not exceed the
loss of outer hair cell function at 9 months of age. Losses are greater
in all transgenic genotypes than the B6 group.
Right and left cochlear ABR thresholds in the 10-month-old
animals were compared to assess expected differences due to
random accumulation of mitochondrial mutations. Although some
subjects showed equally poor hearing in the two ears, most animalsFig. 3. Mean ABR thresholds for each genotype as a function of age. By 7 months of
age, transgenic homozygous (D257A) and heterozygous (D257A/þ) mice have higher
thresholds than the background, B6 mice, but all transgenic groups experienced some
amount of hearing loss and are not signiﬁcantly different from each other. Negative
error bars represent the standard deviation for the B6 mice. Positive error bars
represent the standard deviation for the D257A mice. Stars represent ages where the
D257A and D257A/þmice have greater thresholds than the B6 mice (ANOVA, p < 0.05,
Fisher’s Least Signiﬁcant Difference post-hoc test).possessed hearing that was worse in one ear or the other. The
differences among the genotypes were assessed by taking the
absolute value of the difference between the left and right ears for
each animal (Fig. 5). As predicted, D257A mice had a larger differ-
ence in ABR threshold between the two cochleas than the hetero-
zygous or wild-type mice (p < 0.05, ANOVA, Fisher’s Least
Signiﬁcant Difference post-hoc test). The ahl allele also appears to
affect each ear independently, as the B6 mice also had a large inter-
ear difference.
3.3. Acoustic trauma
In order to evaluate the consequences of the accumulation of
mtDNA defects on acoustic trauma, mice were exposed to loud
noise and their recovery measured. A separate cohort of mice
representing all four genotypes was selected to undergo noiseFig. 4. Relationship between mean DPOAE and ABR thresholds in response to an 8 kHz
stimulus at 9 months of age for each genotype. The line represents equal thresholds in
the 2 measures. The neural loss is only slightly greater than the sensory loss.
Fig. 5. Mean (standard deviation) ABR threshold differences between the left and right
cochlea for individual mice at 10 months of age for each of the 4 genotypes of mice.
The D257A mice have a larger absolute difference in ABR threshold between the two
cochleas than the heterozygous (D257A/þ) or wild-type (WT) mice (ANOVA, p < 0.05,
Fisher’s Least Signiﬁcant Difference post-hoc test). The B6 mice also had large
threshold differences between the 2 ears.
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demonstrated a temporary ABR threshold shift (TTS) of 34 dB in
both ears (Fig. 6, top panel). D257A mice showed only a mean of
22 dB TTS and this difference was signiﬁcant at p < 0.001 (ANOVA,Fig. 6. Mean (standard deviation) ABR threshold shifts in response to 2 h of noise
exposure (8e16 kHz) at 95 dB SPL (top panel) or 105 dB SPL (lower panel). All mice
were 2 months of age at the time of the noise exposure (n ¼ 4 in each group). The
amount of TTS is signiﬁcantly less in D257A mice relative to B6 mice following the
95 dB noise exposure (p < 0.001, ANOVA, Fisher’s Least Signiﬁcant Difference post-hoc
test), but not at the 105 dB exposure level. The PTS measured a month after the noise
exposure, however was no different among the genotypes.Fisher’s Least Signiﬁcant Difference post-hoc test). Onemonth later,
the threshold shifts had diminished to 8 and 10 dB for the B6 and
D257A groups, respectively, a difference that is not signiﬁcant
(p ¼ 0.061). Heterozygous andWT transgenic subjects experienced
mean TTS and permanent threshold shifts (PTS) between the B6
and D257A values and no differences between these other groups
proved signiﬁcant. Mice that were exposed to 105 dB noise
demonstrated TTS between 20 and 80 dB and PTSs between 22 and
50 dB. No signiﬁcant differences were seen among the 4 genotypes
(Fig. 6, lower panel).
3.4. COX activity
Twenty-three cochleas at 10e11 months of age were used to
evaluate the endogenous COX activity of cochlear cells. This activity
is recognized as the density of the DAB staining in histological
sections. The cells with the densest stain were those of the stria
vascularis, followed by the suprastrial and infrastrial cells of the
spiral ligament, the neurons and the hair cells. The supralimbal
cells that form the junction of Reissner’s membrane with the spiral
limbus also showed intense staining in all genotypes (Fig. 7). While
the marginal, intermediate and basal cells of the stria vascularis all
stainedwith the same density in an individual section, the neuronal
staining density within one cross-section of Rosenthal’s canal
exhibited a large variability in the stain intensity. While the D257A
mice and the D257A/þ mice were scored with slightly lower
densities for the all the evaluated structures, statistical testing did
not support a quantiﬁable difference in the stain density among the
genotypes.
3.5. Pathology
Cochlear sections from each genotype (B6, n ¼ 4; WT, n ¼ 11;
D257A/þ, n ¼ 18; D257A, n ¼ 17) were evaluated in young subjects
(3e6 months of age) and older subjects (10e16 months). The
cochleas from the young mice appeared normal with the exception
that several cochleas from the D257A (n ¼ 3 of 6) and D257A/þ
groups (n ¼ 2 of 8) appeared to have a small loss of neurons at the
apical end of the ganglion. This was identiﬁed as larger spaces than
normal between neurons within Rosenthal’s canal. At 10 months of
age the most consistent and notable pathology in all genotypes was
the loss of the organ of Corti and the auditory neurons in the basal,
high frequency, region of the cochlea (Fig. 8). We attribute this to
the B6 background strain which has long been known to have this
pathology (Mikaelian et al., 1974; Keithley et al., 2004).
The most unusual pathology associated with the transgenic
mice was the clumping of neurons at the apical end of Rosenthal’s
canal (Fig. 7, D257A/þ and D257A; Fig. 8). Rather than maintaining
extracellular space between adjacent cells, 3e6 neurons often
appeared adherent to one another. Three to 5 “clumps” were seen
in 8 of 8 cochleas from D257A mice ranging in age from 10 to
12 months of age. Six of 7 D257A/þ mice aged 10e17 months also
had clumped neurons in the apical turn and 0 of 7 WT mice
between the ages of 10 and 15 months had clumped neurons. No
cochleas from mice less than 10 months had clumps of neurons
and none of the B6 mice cochleas had clumped neurons, regard-
less of age.
The stria vascularis showed no obvious pathology although we
did not perform any speciﬁc quantitative measures of its area or
volume in individual sections. The organ of Corti also appeared
without gross pathology in any region other than the basal turn,
where it was completely missing in most aged mice of all geno-
types. The loss of scattered hair cells is difﬁcult to quantify in frozen
sections, but all aged cochleas did show evidence of some loss of
hair cells.
Fig. 7. Photomicrographs (Nomarski optics) of cytochrome oxidase enzymatically labeled cells in 10-month-old mice cochleas from each genotype: B6, wild-type, D257A/þ and
D257A. In all 4 genotypes labeled cells include the sensory cells, neurons, cells of the stria vascularis (arrowheads in D257A photo), supra- and infrastrial cells in the spiral ligament
and Reissner’s membrane. In addition to the cells known to contain high densities of mitochondria, there is dark staining of the supralimbal cells (star in the D257/þ photo) that
form the junction of Reissner’s membrane with the spiral limbus. In many of the cochleas from the D257A/þ and D257A mice the neurons at the apical end of Rosenthal’s canal
appeared to be clumped together (arrows). ST, scala tympani, Scale bar for all ﬁgures, 50 mm.
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Transgenic mice that lack the nuclear-encoded polymerase
gamma necessary to repair mtDNA, have an increased rate of
mtDNA point mutation (Trifunovic et al., 2004; Kujoth et al., 2005),
large deletions in their mtDNA (Kujoth and Prolla, 2008) as well as
perturbations in the mtDNA replication cycle (Bailey et al., 2009).
Their production of ROS is normal, although they demonstrateFig. 8. Photomicrogragh demonstrating the loss of the organ of Corti (arrowheads) and
the auditory neurons in the basal region (star) of the cochlea in a 12-month-old D257A
mouse. These pathologies are representative of that normally seen in B6 mice, the
background strain, at this age. In addition to this expected, B6 pathology, there are
some clumped neurons (arrows) at the apical end of Rosenthal’s canal. This is unique
to the D257A and D257A/þ mice. Hematoxylin & eosin stained parafﬁn section, 10 mm.
Scale bar, 100 mm.respiratory chain dysfunction (Trifunovic et al., 2005). They also
display signs of premature aging including premature hearing loss
(Kujoth et al., 2005; Niu et al., 2007; Yamasoba et al., 2007; Someya
et al., 2008). This transgenic mouse was originally created as
a potential model for human aging. While it possesses many
features of aging, this fact alone does not prove that mtDNA muta-
tions are responsible for aging. Certainly, though, such mutations
give rise to pathology that is similar to age-related hearing loss or
presbycusis and mtDNA mutations exist in aged human cochlear
cells (Fischel-Ghodsian et al., 1997; Bai et al., 1997). For this reason
these mice are an interesting model for the study of age-related
hearing loss and how mtDNA mutations can give rise to it.
Though the B6 background strain, that carries the ahl allele of
the Cdh23 gene, has been well described, the D257A transgenic
mouse model is new and complicated. The gene in question, PolgA,
is transferred on nuclear, chromosomal DNA and is expected to
distribute according to Mendelian principles. The manifestation of
the transgenic effect, however, is determined in part through
maternally-derivedmtDNA present in the cytoplasm of the ovum at
the time of conception. In mice with only one copy of wild-type
PolgA (D257A/þ), it is unknown how much baseline mtDNA
damage may be present. It is known, however, that by the time
D257A mice reach the age of 5 months, they demonstrate mtDNA
mutation frequencies of 4e10 per mitochondrial genome (Kujoth
et al., 2005) and even low levels of deletion may have a physio-
logical effect (Vermulst et al., 2009). It is to be expected, therefore,
that animals born to heterozygous mothers will receive mito-
chondria from the ovum’s cytoplasm possessing some existent
level of mtDNA mutation. Even if the progeny possess two func-
tional copies of PolgA, preexistent mtDNA mutations or deletions
inherited from the mother, will not necessarily be restored, and as
cells divide, they will pass the mutated mtDNA to each daughter
cell. There remains much uncertainty regarding the level of mito-
chondrial recombinationwithin a cell and howmuch repair may be
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mice were used as the background stain for the development of the
D257A transgenic mouse, the pathology associated with the ahl
allele can be separated from the D257A pathology. We did not
conﬁrm the presence of ahl in any of our mice.
As only heterozygous females were used for breeding purposes
in our colony, we chose to follow four cohorts of animals from 2 to
10 months of age, including two different groups with wild-type
copies of mtDNA polymerase, one strain derived from our own
colony (identiﬁed asWT), and the other separate representatives of
the background strain (identiﬁed as B6). Although body weight
measures over time (Fig. 1) support the hypothesis that the D257A
mice are phenoltypically distinct from the other transgenic geno-
types, the hearing data do not show a statistically signiﬁcant
divergence in loss between transgenic groups raised in our facility.
That is, the hearing of the D257A mice does not differ from the
D257A/þ or wild-type mice. All groups do demonstrate a larger
hearing loss than the B6 mice and there is evidence that low
frequency loss is greater in transgenic mice relative to background
mice. It appears then, as previously reported, that even a small
amount of mutated mtDNA, can affect the progeny to some degree
(Vermulst et al., 2009).
Measures of otoacoustic emissions illustrated a progressive
hearing loss, most pronounced at the high frequencies of 16, 20 and
28 kHz, in all 4 genotypes. However, it is important to acknowledge
that the background strain (C57BL/6 or B6) on which D257A mice
were developed, possesses the ahl allele which is associated with
accelerated age-related hearing loss (Noben-Trauth et al., 2003;
Mikaelian et al., 1974; Keithley et al., 2004). Nonetheless, by the
age of 7 months, transgenic PolgA mice had developed an even
larger hearing loss than the B6 mice. In addition, the mtDNA
transgenic mice began to demonstrate low frequency hearing loss
(4 and 8 kHz) at 7 months of agewhen themtDNA are likely to have
greater than 4e10 mutations per mitochondrial genome (Kujoth
et al., 2005). Measures of ABR thresholds also showed greater
hearing loss in transgenic than in B6 mice, though there was no
statistical difference between the D257A, heterozygous and wild-
type mice. It is possible that a distinction may have become
evident as transgenic mice aged past 10 months, since wild-type
mice did not appear to be losing their hearing as rapidly as
D257A or heterozygous mice. It is also possible that the assembly of
larger cohorts would have provided more clear distinctions among
the transgenic groups. Our results are similar to what has previ-
ously been reported regarding the effect of the ahl allele on the time
of onset of hearing loss, but the magnitude of the losses were not as
great in our sample.
Under histopathological examination, some features were
discovered in all genotypic groups, while some were not. The most
consistent and notable ﬁndingwas the loss of the organ of Corti and
the auditory neurons in the basal, high frequency region of the
cochlea in all genotypes, at 10 months of age and older. A very
unique ﬁnding to the D257A and D257A/þ mice was the appear-
ance of clumped auditory neurons at the apical end of Rosenthal’s
canal. To the best of our knowledge, the only previous report of
such pathology in the spiral ganglion was in relation to a mutant
mouse described as “deafness” (dn/dn) (Webster, 1985). The gene
that underlies this pathology has not been identiﬁed. Given that
there is a great deal of change in the regulation of gene transcrip-
tion in the polgA transgenic mice, it is possible that the gene giving
rise to the deafness phenotype is down-regulated in D257A mice.
One category of genes thatmight be responsible is the cell adhesion
genes, many of which are down-regulated in these mice (Someya
et al., 2008). In contrast to the hearing data that do not allow
differentiation between the D257A and wild-type transgenic mice,
this clumping was only present in D257A and D257A/þ mice. Thisobservation is consistent with the proposal that a certain load of
mtDNA mutations and/or deletions is required to establish a situa-
tion where neuronal aggregation may occur.
The enzymatic activity of COX was assessed in our assay with
the purpose of identifying speciﬁc cell types in histological sections
that produce relatively more ATP. Sections of cardiac muscle tissue
from transgenic D257A mice have already been shown to stain in
a mosaic pattern, rather than a homogeneous pattern, when
examined for COX activity indicating that some myocytes had
deﬁcient COX activity (Trifunovic et al., 2004). Stained sections of
duodenum, heart and brain also implicated individual cells with
reduced COX activity in PolgAmice (Vermulst et al., 2008). With our
application of this assay, cochlear cells with the highest density of
mitochondria were the cells that labeled most strongly. These
proved to be the cells of the stria vascularis, the supra- and
infrastrial ﬁbrocytes of the spiral ligament, the auditory neurons,
sensory cells and the cells at the attachment of Reissner’s
membrane to the limbus. Though we expected to reveal a differ-
ence in the enzymatic activity of COX in cochlear cells among our 4
genotypic groups, there was no observable difference. In all
subjects, the supralimbal cells that form the junction of Reissner’s
membrane with the spiral limbus demonstrated intense staining.
Though we did not conﬁrm the presence of mitochondria with
electron microscopy we may presume that these particular cells
contain a signiﬁcant concentration of mitochondria. As evidence of
their importance in cochlear energy production, they are known to
express the a2 and b1 mRNA subunit isoforms of Na, K-ATPase
(Ryan and Watts, 1991). Although in any section the neuronal
staining ranged from very dark to very faint, the PolgAmice did not
possess a greater number of pale neurons than the other genotypes.
We interpret this result to reﬂect the lack of a reliable reduction in
the functional COX enzyme present in transgenic mitochondria.
Any hearing loss therefore, cannot be attributed to a particular COX
deﬁciency. It is possible that the variation in label pattern among
the neurons reﬂects the variation in spontaneous discharge rate of
the neurons. It is also possible that the neurons are very sensitive to
decrements in COX activity and degenerate rapidly when this
occurs making the loss of neurons a better reﬂection of the loss of
activity than the label density. The 10-month-old PolgA mice did
demonstrate a loss of neurons at the apical end of the canal that
was more pronounced than the other genotypes investigated.
Acoustic traumawas also employed to test the effect of the PolgA
mutation on hearing loss. There is a growing body of evidence
suggesting that cellular damage from traumatic noise exposure is
a result of ROS generation in cochlear sensory cells (Yamasoba et al.,
2005; Bielefeld et al., 2005; Le Prell et al., 2007; Lin et al., 2009;
Vlajkovic et al., 2009). Due to the reputed mitochondrial insufﬁ-
ciency in D257A mice, we hypothesized that cochlear cells would
fail to be driven by high intensity noise though they have been
shown to generate ROS (Trifunovic et al., 2005). We initially
selected a relatively low-level noise exposure in order to be situated
at the threshold of the phenomenon rather than to overwhelm it.
Immediately following exposure to a 95 dB octave-band noise,
threshold increases were, in fact, smaller in the D257Amice relative
to the wild-type mice, while exposure to the 105 dB noise band did
not show a difference in the magnitude of the threshold shift. The
difference in response at 95 dBmay be attributable to themetabolic
inability (Edgar et al., 2009) of the transgenic cochlea to respond to
the stimulus. Because of this inability, fewer ROS are generated and
less damage occurs. The higher amplitude stimulus activates
a longer length of the organ of Corti and may thereby generate
enough ROS to create a threshold shift. While at this point we may
only speculate regarding the mechanism underlying this
phenomenon, these mice may prove useful for establishing cellular
mechanisms of noise-induced hearing loss.
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Mice with any level of exposure to mutated mtDNA polymerase
gamma developed a low-frequency hearing loss at an earlier age
than the background strain, B6, but the 3 PolgA transgenic mice
genotypes did not differ among themselves in the degree of hearing
loss. The cochleas of 10-month-old PolgA animals had severe
sensorineural degeneration in the basal turn as well as neural
degeneration in the apical turn. Surviving neurons in the apical
turnwere often clumped together. This pathology in the apical turn
was not seen in wild-type transgenic mice or control, B6 mice.
Cellular degeneration in the basal turn of the cochleawas seen in all
genotypes andmost likely reﬂects the effect of the ahl allele. D257A
transgenic mice were protected against the development of TTS
when relatively low noise levels were utilized. This ﬁnding is
consistent with the proposal that oxidative phosphorylation and
ROS are involved in acoustic trauma. Though the process of accel-
erated mtDNA mutation contributes to the development of
premature aging, it is unlikely to be the only factor involved in age-
related hearing loss in humans or other mammals.
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